Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer
Authors:
Open Access
- 29 March 2013
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 5 (6) , 1943-1947
Abstract
Despite a large number of studies indicating that celecoxib plays an important role in the prevention and treatment of tumors, the detailed molecular mechanisms are not well understood. The aim of the present study was to investigate the effect of celecoxib on insulin-like growth factor 1 (IGF-1)-induced growth and invasion in non-small cell lung cancer (NSCLC). For these experiments, IGF-1-induced cell growth and invasion were analyzed in A549 cells in the presence and absence of celecoxib. The effects of celecoxib on the expression of phosphorylated type-1 IGF receptor (IGF‑1R) and phosphorylated AKT (p-AKT) were examined using western blot analysis. The influence of celecoxib on IGF-binding protein-3 (IGFBP-3) expression was analyzed using ELISA. Celecoxib inhibited IGF-1-stimulated growth and invasion in a dose-dependent manner. Celecoxib also reduced the expression of IGF-1R, IGFBP-3 and phosphorylation of AKT. The results suggest that modulating the IGF axis may be a new mechanism for the anticancer effect of celecoxib on NSCLC.Keywords
This publication has 31 references indexed in Scilit:
- Cyclooxygenase-2 inhibitors induce anoikis in osteosarcoma via PI3K/Akt pathwayMedical Hypotheses, 2012
- NS398 induces apoptosis in non-small cell lung cancer cellsJournal of Cancer Research and Clinical Oncology, 2011
- Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanismsCell Death & Disease, 2011
- Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study GroupEuropean Journal of Cancer, 2011
- Serum IGF-1 Concentrations Change With Soy and Seaweed Supplements in Healthy Postmenopausal American WomenNutrition and Cancer, 2011
- COX-2 as a target for cancer chemotherapyPharmacological Reports, 2010
- Cyclooxygenase‐2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancerInternational Journal of Cancer, 2009
- Cyclooxygenase-2 Modulates the Insulin-Like Growth Factor Axis in Non–Small-Cell Lung CancerCancer Research, 2004
- Potential Prophylactic Measures Against Postoperative Immunosuppression: Could They Reduce Recurrence Rates in Oncological Patients?Annals of Surgical Oncology, 2003
- Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.2003